Xinzheng Dai

1.3k total citations
29 papers, 877 citations indexed

About

Xinzheng Dai is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Xinzheng Dai has authored 29 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Hepatology and 7 papers in Cancer Research. Recurrent topics in Xinzheng Dai's work include Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xinzheng Dai is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xinzheng Dai collaborates with scholars based in China, Taiwan and United Kingdom. Xinzheng Dai's co-authors include Xuehao Wang, Xiaofeng Qian, Zhibo Hou, Xiangcheng Li, Xiaofeng Qian, Xiaolin Li, Haitao Yin, Chuanyong Zhang, Huae Xu and Jing Ge and has published in prestigious journals such as The Journal of Immunology, Hepatology and Scientific Reports.

In The Last Decade

Xinzheng Dai

29 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinzheng Dai China 18 407 196 196 148 144 29 877
Weiyang He China 18 715 1.8× 89 0.5× 343 1.8× 181 1.2× 154 1.1× 40 1.0k
Youhong Jiang China 20 584 1.4× 205 1.0× 272 1.4× 61 0.4× 60 0.4× 60 992
Fazong Wu China 17 507 1.2× 241 1.2× 333 1.7× 56 0.4× 256 1.8× 38 1.0k
Deqiang Wang China 18 506 1.2× 325 1.7× 374 1.9× 116 0.8× 320 2.2× 94 1.1k
Guodong Xu China 18 450 1.1× 107 0.5× 338 1.7× 89 0.6× 152 1.1× 60 955
Ruipeng Song China 22 997 2.4× 275 1.4× 651 3.3× 178 1.2× 145 1.0× 51 1.7k
Jiaming Huang China 17 518 1.3× 216 1.1× 433 2.2× 89 0.6× 130 0.9× 51 932
Chengyong Dong China 17 387 1.0× 201 1.0× 251 1.3× 110 0.7× 100 0.7× 29 721
Lei Dai China 18 449 1.1× 225 1.1× 191 1.0× 108 0.7× 99 0.7× 56 976

Countries citing papers authored by Xinzheng Dai

Since Specialization
Citations

This map shows the geographic impact of Xinzheng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinzheng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinzheng Dai more than expected).

Fields of papers citing papers by Xinzheng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinzheng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinzheng Dai. The network helps show where Xinzheng Dai may publish in the future.

Co-authorship network of co-authors of Xinzheng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xinzheng Dai. A scholar is included among the top collaborators of Xinzheng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinzheng Dai. Xinzheng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yue, Lei, Xiaozhang Xu, Shipeng Dai, et al.. (2023). Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization. Scientific Reports. 13(1). 14092–14092. 10 indexed citations
2.
Zhang, Liren, Jiali Xu, Ruizhi Zhang, et al.. (2023). Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. Journal of Hepatology. 80(1). 82–98. 81 indexed citations
3.
Chen, Xiaofeng, Wei Li, Xiaofeng Wu, et al.. (2022). Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study. Frontiers in Oncology. 12. 909035–909035. 32 indexed citations
4.
Dai, Shipeng, et al.. (2022). Emerging mechanisms progress of colorectal cancer liver metastasis. Frontiers in Endocrinology. 13. 1081585–1081585. 33 indexed citations
5.
Dai, Xinzheng, Yong Shi, Xiaowen Zhu, et al.. (2021). CHI3L1 alleviate acute liver injury by inhibiting Th1 cells differentiation through STAT3 signaling pathway. Annals of Translational Medicine. 9(7). 529–529. 6 indexed citations
6.
Yue, Lei, Xinzheng Dai, Dawei Rong, et al.. (2021). Perspectives on Immunotherapy of Metastatic Colorectal Cancer. Frontiers in Oncology. 11. 659964–659964. 22 indexed citations
7.
Liu, Zheng, Jian Gu, Qin Zhu, et al.. (2020). Decreased Foxp3 and function of Tregs caused immune imbalance and liver injury in patients with autoimmune liver diseases post-liver transplantation. Annals of Translational Medicine. 8(8). 534–534. 7 indexed citations
8.
Zhou, Haoming, Yu Sun, Qingyuan Wang, et al.. (2020). N-acetylcysteine alleviates liver injury by suppressing macrophage-mediated inflammatory response post microwave ablation. International Immunopharmacology. 85. 106580–106580. 8 indexed citations
9.
Lu, Hao, et al.. (2019). Gal-1 regulates dendritic cells-induced Treg/Th17 balance though NF-κB/RelB-IL-27 pathway. Annals of Translational Medicine. 7(22). 628–628. 12 indexed citations
10.
Dai, Xinzheng, Hui Zhang, Liyong Pu, et al.. (2018). Precoagulation with microwave ablation for hepatic parenchymal transection during liver partial resection. International Journal of Hyperthermia. 36(1). 145–149. 5 indexed citations
11.
Zuo, Xueliang, Zhiqiang Chen, Juan Cai, et al.. (2018). 5‐Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT‐Dependent and Independent Manners. Hepatology. 69(5). 2031–2047. 45 indexed citations
12.
Rao, Jianhua, Feng Zhang, Lu Hao, et al.. (2017). Effects of multimodal fast-track surgery on liver transplantation outcomes. Hepatobiliary & pancreatic diseases international. 16(4). 364–369. 24 indexed citations
13.
Rao, Jianhua, et al.. (2016). Hepatic perivascular epithelioid cell tumor in three patients. Hepatobiliary & pancreatic diseases international. 15(6). 660–664. 12 indexed citations
14.
Dai, Xinzheng. (2013). Gallstone ileus: Case report and literature review. World Journal of Gastroenterology. 19(33). 5586–5586. 49 indexed citations
15.
Dai, Xinzheng, Haitao Yin, Lingfei Sun, et al.. (2013). Potential Therapeutic Efficacy of Curcumin in Liver Cancer. Asian Pacific Journal of Cancer Prevention. 14(6). 3855–3859. 48 indexed citations
16.
Zhang, Hao, Xiaolin Li, Jing Ding, et al.. (2012). Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). International Journal of Pharmaceutics. 441(1-2). 261–268. 93 indexed citations
17.
Hou, Zhibo, Haitao Yin, Cong Chen, et al.. (2012). microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Molecular Medicine Reports. 6(3). 501–506. 45 indexed citations
18.
Dai, Xinzheng, Jing Ge, Xuehao Wang, et al.. (2012). OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncology Reports. 29(1). 155–160. 88 indexed citations
19.
Yin, Haitao, Rui Guo, Yong Xu, et al.. (2011). Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. Acta Biochimica et Biophysica Sinica. 44(2). 147–153. 50 indexed citations
20.
Dai, Xinzheng, et al.. (1994). Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form.. The Journal of Immunology. 153(9). 4088–4098. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiyang He Breakdown of academic impact, for papers by Youhong Jiang Breakdown of academic impact, for papers by Fazong Wu Breakdown of academic impact, for papers by Deqiang Wang Breakdown of academic impact, for papers by Guodong Xu Breakdown of academic impact, for papers by Ruipeng Song Breakdown of academic impact, for papers by Jiaming Huang Breakdown of academic impact, for papers by Chengyong Dong Breakdown of academic impact, for papers by Lei Dai
Rankless by CCL
2026